1. Home
  2. ALT vs CLFD Comparison

ALT vs CLFD Comparison

Compare ALT & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • CLFD
  • Stock Information
  • Founded
  • ALT 1997
  • CLFD 1979
  • Country
  • ALT United States
  • CLFD United States
  • Employees
  • ALT N/A
  • CLFD N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • CLFD Telecommunications Equipment
  • Sector
  • ALT Health Care
  • CLFD Utilities
  • Exchange
  • ALT Nasdaq
  • CLFD Nasdaq
  • Market Cap
  • ALT 457.0M
  • CLFD 524.0M
  • IPO Year
  • ALT N/A
  • CLFD N/A
  • Fundamental
  • Price
  • ALT $8.41
  • CLFD $30.06
  • Analyst Decision
  • ALT Buy
  • CLFD Strong Buy
  • Analyst Count
  • ALT 7
  • CLFD 3
  • Target Price
  • ALT $20.00
  • CLFD $46.67
  • AVG Volume (30 Days)
  • ALT 4.3M
  • CLFD 171.7K
  • Earning Date
  • ALT 11-12-2024
  • CLFD 11-07-2024
  • Dividend Yield
  • ALT N/A
  • CLFD N/A
  • EPS Growth
  • ALT N/A
  • CLFD N/A
  • EPS
  • ALT N/A
  • CLFD N/A
  • Revenue
  • ALT $52,000.00
  • CLFD $166,705,000.00
  • Revenue This Year
  • ALT N/A
  • CLFD $15.12
  • Revenue Next Year
  • ALT N/A
  • CLFD N/A
  • P/E Ratio
  • ALT N/A
  • CLFD N/A
  • Revenue Growth
  • ALT N/A
  • CLFD N/A
  • 52 Week Low
  • ALT $2.50
  • CLFD $24.78
  • 52 Week High
  • ALT $14.84
  • CLFD $44.83
  • Technical
  • Relative Strength Index (RSI)
  • ALT 58.51
  • CLFD 36.30
  • Support Level
  • ALT $6.95
  • CLFD $27.06
  • Resistance Level
  • ALT $11.16
  • CLFD $38.51
  • Average True Range (ATR)
  • ALT 0.93
  • CLFD 1.73
  • MACD
  • ALT 0.02
  • CLFD -0.50
  • Stochastic Oscillator
  • ALT 41.51
  • CLFD 26.20

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About CLFD Clearfield Inc.

Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.

Share on Social Networks: